24 - 27 January 2022

Dubai World Trade Centre

5 January - 28 February

Butterfly iQ+: Transforming Health Care to the Next Generation

 

Butterfly Networks

 

Wednesday 26th January | 15:30

Transformation Zone | S2.D70

 

Product description


Butterfly IQ+


Abdul Latif Jameel Health introduces the Butterfly IQ+ - The world's first, single probe, whole-body ultrasound solution.   A single probe, whole-body ultrasound solution. Butterfly iQ+ is designed to make ultrasound easy to use. Once connected to our iOS or Android app, select from 22 presets in seconds with the swipe of a finger — and start scanning. Technology ahead of its time. Butterfly iQ+ is powered by our next-gen, Ultrasound-on-Chip™, which allows us to push the limits of what’s possible.

 

Company bio


Abdul Latif Jameel Health introduces: Butterfly Networks


Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel, and Butterfly Network, Inc. (NYSE: BFLY), an innovative digital health company working to democratize medical imaging and contribute to the aspiration of global health equity, today announced a strategic distribution partnership to broaden the availability of Butterfly iQ+ – the world’s only single probe, whole-body handheld ultrasound solution.

Presenters


Dr. Akram Bouchenaki
CEO Abdul Latif Jameel Health

Akram Bouchenaki is Chief Executive Officer of Abdul Latif Jameel Health, Abdul Latif Jameel’s health care business, focusing on accelerating access to modern medical care while addressing unmet medical needs in developing markets around the World. Abdul Latif Jameel Health is part of Abdul Latif Jameel, a collective of independent international, family-owned and diversified businesses, founded in 1945 by the late Abdul Latif Jameel.

Dr. Bouchenaki joins Abdul Latif Jameel Health after 25 years of operational and strategic roles in the pharmaceutical and healthcare sectors, including global leadership roles in ‘big-pharma’ corporates as well as in top California-based biotech, where he was an executive director for Africa covering the largest markets on the continent.

Akram has extensive knowledge and experience of both generics and branded medicines in established as well as key emerging markets across the world. These include Africa’s most significant markets, Brazil, and Mexico, having co-founded a fast-growing start-up to commercialize medicines in Latin America.

Akram holds a Doctorate in Pharmacy from Université de Paris V, France. He has lived and worked in 9 different countries across 5 continents. He speaks French, Spanish, Arabic, Portuguese and English.

Dr. Peter Weimersheimer
VP Clinical Implementation, Butterfly Networks Inc.

Dr. Peter Weimersheimer is an emergency physician and Professor of Surgery at the University of Vermont, USA. He is the founder and Director of the UVM EM Clinical Ultrasound Program and Regional Ultrasound Director of a seven hospital regional emergency medical system. He has over 20 years of experience in clinical ultrasound and ultrasound education. His interests include thoracic ultrasound, ultrasound-guided regional anesthesia, ultrasound education, and use of ultrasound in resource limited settings.